Contraline, Inc.

Biotechnology · CHARLOTTESVILLE, VA

BiotechnologySEC Form D

Contraline, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 10, 2026, reporting $55,804,741 raised toward a $115,929,658 offering.

Incorporated in Delaware and based in CHARLOTTESVILLE, VA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Contraline, Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Kevin S EisenfratsExecutive Officer · Director · Promoter
  • Martin J EmersonDirector
  • Gurdane BhutaniDirector
  • Iris Van Alderwerelt van RosenburghDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$7.0MRaised

Ovelle Bio Corp.

BiotechnologyDOVER, DE
Jun 2, 2026View SEC Form D
$29.0KRaised

Thiogenesis Therapeutics, Corp.

BiotechnologyTORONTO, A6
Jun 1, 2026View SEC Form D
$22.9KRaised

Conexeu Sciences Inc.

BiotechnologyRENO, NV
May 28, 2026View SEC Form D
$100.0KRaised

Barricade Therapeutics Corp

BiotechnologyFORT WORTH, TX
May 27, 2026View SEC Form D
$1.2MRaised

SalivIQ Diagnostics Inc.

BiotechnologyHARRISONBURG, VA
May 26, 2026View SEC Form D